TheGame46
Member
Ectotropin Profile
Summary: The active ingredient in Ectotropin is [D-Lys³] GROWTH HORMONE RELEASING PEPTIDE-6. Studies have shown that clinical administration of [D-Lys³] GHRP-6 effectively decreased appetite, decreased body fat , lowered glucose blood levels, increased lean skeletal muscle, and lowered cholesterol, triglycerides, and free fatty acids. Ectotropin uses the newest peptide delivery technology that does not go through the digestive system but passes directly into you blood stream through mechanism regulated by you own cheek cells. (see below for details)
Cell-Mediated™ (D-Lys3 ) GHRP-6
(for oral use)
100% Bioavailability, Orally Active, Sustained 24-48 hours
Each kit contains:
4.0mg Cell-Mediated™ (D-Lys3 ) GHRP-6
20 individually sealed oral syringes for ease in daily
dosing, no measurements, no hassles.
Each oral syringe contains:
200mcg Cell-Mediated™ (D-Lys3 ) GHRP-6
sustained 24-48 hrs
0.5 cc's (0.661g) EctoTropin-6™
SUGGESTED RETAIL: $140.00
What is [D-Lys³] GHRP-6? [D-Lys³] GHRP-6 is a Ghrelin and GHRP-6 antagonist (anti-Ghrelin). An antagonist is an opposing or resistant structure in relation and tends to neutralize or impede some action or effect. In this case, the [D-Lys³] GHRP-6 is actually a selective antagonist of the cognate ghrelin receptor, i.e. the GH-secretagogue receptor (GSR).
Studies have shown that clinical administration of [D-Lys³] GHRP-6 effectively decreased appetite, decreased body fat , lowered glucose blood levels, increased lean skeletal muscle, and lowered cholesterol, triglycerides, and free fatty acids. The remarkable potential of this peptide is for blocking receptor bonding of ghrelin. When weight loss is desired, many drawbacks in today's available forms of appetite suppressing diet aids are that the body still continuously signals production of ghrelin. Ghrelin is actually produced and binds at a more rapid rate when the body goes into a fasting or dieting state. Some forms of obesity have been linked to higher production levels of ghrelin which trigger appetite stimulation and faster gastric emptying (in layman's term, quicker release of food into digestion and out of stomach, allowing more space to eat again and sooner). This creates a constant struggle for dieters trying to reduce food intake because their body is actually responding to their change in diet and reduction of calories by increasing production of ghrelin. When the appetite has been suppressed during dieting without also suppressing ghrelin (such as stimulant type appetite suppressants), a dieter will actually have higher levels than prior to their diet, causing a quicker increase of appetite and stored weight gain when the appetite suppressing supplement is discontinued.
Another positive finding is the decreased glucose levels after repeated administration; with less glucose to burn the body is able to burn stored and/or fat intake. The sustained increase in skeletal muscle mass is relative to the increase in growth hormone production which further support the positive beneficial health findings due to supplementation of this remarkable peptide. Clinical studies and active research related to this peptide continue to show the potential base for a safer, alternative to supplemental diet products.
Ectotropin-6™ will prove to be the most advanced, most effective and safest product for weight loss to ever hit the market. Dieters will be able to target the source of appetite stimulation and cravings, genetically, for the first time ever. This product will not only subdue the appetite naturally and more comfortably, but will actually slow the rate of gastric emptying enabling an individual to decrease food intake and meal frequency without the common empty feelings, fatigue and anxiety associated with extreme diet fluctuations. The downfall of most available appetite control alternatives is their lack of control of rebound related appetite suppression consequences. As a matter of fact, the clinical study cited below observes the benefits of supplementing [D-Lys³] GHRP-6 as a means to counter act the diet induced obesity that has become common with current diet aid product use.
Abstracts and Article Links
Antagonism of ghrelin receptor reduces food intake and body weight gain in mice
To gain further insight into the therapeutic potential, we examined whether or not intraperitoneally administered [D-Lys-3]-GHRP-6 produced anorexigenic effects in ob/ob obese mice. [D-Lys-3]-GHRP-6 significantly decreased food intake in ob/ob obese mice as well as in lean mice Finally, we examined the effects of repeated administration of [D-Lys-3]-GHRP-6 on body weight gain and glycaemic control in ob/ob obese mice. Repeated injections of [D-Lys-3]-GHRP-6 significantly lowered body weight gain and blood glucose concentrations without decreasing muscle weight...............
In conclusion, we found that peripherally administered GHS-R antagonists [D-Lys-3]- GHRP-6 and [D-Arg-1, D-Phe-5, D-Trp-7, 9, Leu-11] substance P decreased food intake in lean mice, in mice with diet induced obesity, and in ob/ob obese mice. We also showed that repeated administration of [D-Lys-3]-GHRP-6 decreased body weight gain and improved glycaemic control in ob/ob obese mice.
Summary: The active ingredient in Ectotropin is [D-Lys³] GROWTH HORMONE RELEASING PEPTIDE-6. Studies have shown that clinical administration of [D-Lys³] GHRP-6 effectively decreased appetite, decreased body fat , lowered glucose blood levels, increased lean skeletal muscle, and lowered cholesterol, triglycerides, and free fatty acids. Ectotropin uses the newest peptide delivery technology that does not go through the digestive system but passes directly into you blood stream through mechanism regulated by you own cheek cells. (see below for details)
Cell-Mediated™ (D-Lys3 ) GHRP-6
(for oral use)
100% Bioavailability, Orally Active, Sustained 24-48 hours
Each kit contains:
4.0mg Cell-Mediated™ (D-Lys3 ) GHRP-6
20 individually sealed oral syringes for ease in daily
dosing, no measurements, no hassles.
Each oral syringe contains:
200mcg Cell-Mediated™ (D-Lys3 ) GHRP-6
sustained 24-48 hrs
0.5 cc's (0.661g) EctoTropin-6™
SUGGESTED RETAIL: $140.00
What is [D-Lys³] GHRP-6? [D-Lys³] GHRP-6 is a Ghrelin and GHRP-6 antagonist (anti-Ghrelin). An antagonist is an opposing or resistant structure in relation and tends to neutralize or impede some action or effect. In this case, the [D-Lys³] GHRP-6 is actually a selective antagonist of the cognate ghrelin receptor, i.e. the GH-secretagogue receptor (GSR).
Studies have shown that clinical administration of [D-Lys³] GHRP-6 effectively decreased appetite, decreased body fat , lowered glucose blood levels, increased lean skeletal muscle, and lowered cholesterol, triglycerides, and free fatty acids. The remarkable potential of this peptide is for blocking receptor bonding of ghrelin. When weight loss is desired, many drawbacks in today's available forms of appetite suppressing diet aids are that the body still continuously signals production of ghrelin. Ghrelin is actually produced and binds at a more rapid rate when the body goes into a fasting or dieting state. Some forms of obesity have been linked to higher production levels of ghrelin which trigger appetite stimulation and faster gastric emptying (in layman's term, quicker release of food into digestion and out of stomach, allowing more space to eat again and sooner). This creates a constant struggle for dieters trying to reduce food intake because their body is actually responding to their change in diet and reduction of calories by increasing production of ghrelin. When the appetite has been suppressed during dieting without also suppressing ghrelin (such as stimulant type appetite suppressants), a dieter will actually have higher levels than prior to their diet, causing a quicker increase of appetite and stored weight gain when the appetite suppressing supplement is discontinued.
Another positive finding is the decreased glucose levels after repeated administration; with less glucose to burn the body is able to burn stored and/or fat intake. The sustained increase in skeletal muscle mass is relative to the increase in growth hormone production which further support the positive beneficial health findings due to supplementation of this remarkable peptide. Clinical studies and active research related to this peptide continue to show the potential base for a safer, alternative to supplemental diet products.
Ectotropin-6™ will prove to be the most advanced, most effective and safest product for weight loss to ever hit the market. Dieters will be able to target the source of appetite stimulation and cravings, genetically, for the first time ever. This product will not only subdue the appetite naturally and more comfortably, but will actually slow the rate of gastric emptying enabling an individual to decrease food intake and meal frequency without the common empty feelings, fatigue and anxiety associated with extreme diet fluctuations. The downfall of most available appetite control alternatives is their lack of control of rebound related appetite suppression consequences. As a matter of fact, the clinical study cited below observes the benefits of supplementing [D-Lys³] GHRP-6 as a means to counter act the diet induced obesity that has become common with current diet aid product use.
Abstracts and Article Links
Antagonism of ghrelin receptor reduces food intake and body weight gain in mice
To gain further insight into the therapeutic potential, we examined whether or not intraperitoneally administered [D-Lys-3]-GHRP-6 produced anorexigenic effects in ob/ob obese mice. [D-Lys-3]-GHRP-6 significantly decreased food intake in ob/ob obese mice as well as in lean mice Finally, we examined the effects of repeated administration of [D-Lys-3]-GHRP-6 on body weight gain and glycaemic control in ob/ob obese mice. Repeated injections of [D-Lys-3]-GHRP-6 significantly lowered body weight gain and blood glucose concentrations without decreasing muscle weight...............
In conclusion, we found that peripherally administered GHS-R antagonists [D-Lys-3]- GHRP-6 and [D-Arg-1, D-Phe-5, D-Trp-7, 9, Leu-11] substance P decreased food intake in lean mice, in mice with diet induced obesity, and in ob/ob obese mice. We also showed that repeated administration of [D-Lys-3]-GHRP-6 decreased body weight gain and improved glycaemic control in ob/ob obese mice.